NCT07008092

Brief Summary

Diagnosing acute appendicitis in children remains a clinical challenge, with delayed or incorrect diagnosis potentially leading to serious complications or unnecessary surgery. Prostaglandin E urinary metabolites (PGE-M) have been found elevated in various inflammatory conditions, but their diagnostic value in pediatric appendicitis is not well established. This study aims to assess the potential of PGE-M as a biomarker for acute appendicitis in children. The study will be conducted over 12 months and will include 100 children aged 5 to 17 years presenting with acute abdominal pain. In addition to routine laboratory tests, urinary PGE-M levels will be analyzed. The study involves minimal risk to participants

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jun 2025

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 29, 2025

Completed
4 days until next milestone

Study Start

First participant enrolled

June 2, 2025

Completed
4 days until next milestone

First Posted

Study publicly available on registry

June 6, 2025

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2026

Completed
Last Updated

June 6, 2025

Status Verified

May 1, 2025

Enrollment Period

11 months

First QC Date

May 29, 2025

Last Update Submit

May 29, 2025

Conditions

Keywords

Acute appendicitisPGE-MProstaglandin-E urinary metabolite

Outcome Measures

Primary Outcomes (1)

  • PGE-M

    Levels of prostaglandin E urinary metabolite as measured with ELISA test

    72 hours

Study Arms (3)

Acute appendicitis with rupture

Diagnostic Test: Blood specimen collectionDiagnostic Test: Urine collection

Acute appendicitis without rupture

Diagnostic Test: Blood specimen collectionDiagnostic Test: Urine collection

Control group

Patients with abdominal pain in which acute appendicitis has been ruled out as a cause

Diagnostic Test: Blood specimen collectionDiagnostic Test: Urine collection

Interventions

Blood specimen collection for analysis of C-reactive protein, white blood cell count and neutrophile count.

Acute appendicitis with ruptureAcute appendicitis without ruptureControl group
Urine collectionDIAGNOSTIC_TEST

Urine sample collection for analysis of creatinine and prostaglandin E urinary metabolites

Acute appendicitis with ruptureAcute appendicitis without ruptureControl group

Eligibility Criteria

Age5 Years - 17 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

Patients from 5 to 17 years of age, presenting with acute abdominal pain consistent with diagnosis of acute appendicitis, to Emergency Surgical Department at the University Hospital of Split

You may qualify if:

  • children of age 5 -17 years with acute abdominal pain
  • children with clinical signs of acute appendicitis

You may not qualify if:

  • previous diagnosis of chronic and/or malignant disease
  • children who had previous abdominal surgery
  • pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital of Split

Split, 21000, Croatia

RECRUITING

MeSH Terms

Conditions

AppendicitisAbdominal Pain

Interventions

Blood Specimen CollectionUrine Specimen Collection

Condition Hierarchy (Ancestors)

Intraabdominal InfectionsInfectionsGastroenteritisGastrointestinal DiseasesDigestive System DiseasesCecal DiseasesIntestinal DiseasesPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsSigns and Symptoms, Digestive

Intervention Hierarchy (Ancestors)

Specimen HandlingClinical Laboratory TechniquesDiagnostic Techniques and ProceduresDiagnosisPuncturesSurgical Procedures, OperativeInvestigative Techniques

Central Study Contacts

Tomislav Žuvela, Doctor of Medicine, MD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Doctor of Medicine, Plastic surgery resident

Study Record Dates

First Submitted

May 29, 2025

First Posted

June 6, 2025

Study Start

June 2, 2025

Primary Completion

May 1, 2026

Study Completion

May 1, 2026

Last Updated

June 6, 2025

Record last verified: 2025-05

Data Sharing

IPD Sharing
Will not share

Locations